<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Dynamic International Prognostic Scoring System (DIPSS) Plus for primary myelofibrosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Dynamic International Prognostic Scoring System (DIPSS) Plus for primary myelofibrosis</h1>
<div class="graphic"><div class="figure"><div class="ttl">Dynamic International Prognostic Scoring System (DIPSS) Plus for primary myelofibrosis</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Survival data of 428 patients with primary myelofibrosis evaluated within one year of their diagnosis and stratified by their Dynamic International Prognostic Scoring System (DIPSS) + karyotype + platelet count + transfusion status prognostic scores. Low risk, zero adverse points; n = 46; median survival, approximately 180 months. Intermediate-1 risk, one adverse point; n = 114; median survival, approximately 80 months. Intermediate-2 risk, two or three adverse points; n = 177; median survival, approximately 35 months. High risk, four to six adverse points; n = 91; median survival, approximately 16 months. The p value refers to survival differences between risk groups.</div><div class="graphic_reference">From: Gangat N, Caramazza D, Vaidya R, et al. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol 2011; 29(4):392-7. Reprinted with permission. Copyright © 2011 American Society of Clinical Oncology. All rights reserved.</div><div id="graphicVersion">Graphic 104430 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
